174 related articles for article (PubMed ID: 20299441)
1. Effects of age on the glucose metabolic changes in mild cognitive impairment.
Kantarci K; Senjem ML; Lowe VJ; Wiste HJ; Weigand SD; Kemp BJ; Frank AR; Shiung MM; Boeve BF; Knopman DS; Petersen RC; Jack CR
AJNR Am J Neuroradiol; 2010 Aug; 31(7):1247-53. PubMed ID: 20299441
[TBL] [Abstract][Full Text] [Related]
2. Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.
Del Sole A; Clerici F; Chiti A; Lecchi M; Mariani C; Maggiore L; Mosconi L; Lucignani G
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1357-66. PubMed ID: 18418593
[TBL] [Abstract][Full Text] [Related]
3. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
[TBL] [Abstract][Full Text] [Related]
4. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
5. Unawareness of memory deficit in amnestic MCI: FDG-PET findings.
Nobili F; Mazzei D; Dessi B; Morbelli S; Brugnolo A; Barbieri P; Girtler N; Sambuceti G; Rodriguez G; Pagani M
J Alzheimers Dis; 2010; 22(3):993-1003. PubMed ID: 20858977
[TBL] [Abstract][Full Text] [Related]
6. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.
Womack KB; Diaz-Arrastia R; Aizenstein HJ; Arnold SE; Barbas NR; Boeve BF; Clark CM; DeCarli CS; Jagust WJ; Leverenz JB; Peskind ER; Turner RS; Zamrini EY; Heidebrink JL; Burke JR; DeKosky ST; Farlow MR; Gabel MJ; Higdon R; Kawas CH; Koeppe RA; Lipton AM; Foster NL
Arch Neurol; 2011 Mar; 68(3):329-37. PubMed ID: 21059987
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
Anchisi D; Borroni B; Franceschi M; Kerrouche N; Kalbe E; Beuthien-Beumann B; Cappa S; Lenz O; Ludecke S; Marcone A; Mielke R; Ortelli P; Padovani A; Pelati O; Pupi A; Scarpini E; Weisenbach S; Herholz K; Salmon E; Holthoff V; Sorbi S; Fazio F; Perani D
Arch Neurol; 2005 Nov; 62(11):1728-33. PubMed ID: 16286547
[TBL] [Abstract][Full Text] [Related]
8. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.
Whitwell JL; Shiung MM; Przybelski SA; Weigand SD; Knopman DS; Boeve BF; Petersen RC; Jack CR
Neurology; 2008 Feb; 70(7):512-20. PubMed ID: 17898323
[TBL] [Abstract][Full Text] [Related]
9. Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease.
Förster S; Buschert VC; Buchholz HG; Teipel SJ; Friese U; Zach C; la Fougere C; Rominger A; Drzezga A; Hampel H; Bartenstein P; Buerger K
J Alzheimers Dis; 2011; 25(4):695-706. PubMed ID: 21498904
[TBL] [Abstract][Full Text] [Related]
10. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
Whitwell JL; Przybelski SA; Weigand SD; Knopman DS; Boeve BF; Petersen RC; Jack CR
Brain; 2007 Jul; 130(Pt 7):1777-86. PubMed ID: 17533169
[TBL] [Abstract][Full Text] [Related]
11. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer's disease and amnestic mild cognitive impairment.
Wabik A; Trypka E; Bladowska J; Statkiewicz M; Sąsiadek M; Zimny A
J Transl Med; 2022 Jun; 20(1):259. PubMed ID: 35672750
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
[TBL] [Abstract][Full Text] [Related]
14. Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis.
Clerici F; Del Sole A; Chiti A; Maggiore L; Lecchi M; Pomati S; Mosconi L; Lucignani G; Mariani C
Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):646-57. PubMed ID: 20016455
[TBL] [Abstract][Full Text] [Related]
15. Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.
Ishii H; Ishikawa H; Meguro K; Tashiro M; Yamaguchi S
Int Psychogeriatr; 2009 Feb; 21(1):148-56. PubMed ID: 19040787
[TBL] [Abstract][Full Text] [Related]
16. Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.
Huang KL; Lin KJ; Hsiao IT; Kuo HC; Hsu WC; Chuang WL; Kung MP; Wey SP; Hsieh CJ; Wai YY; Yen TC; Huang CC
PLoS One; 2013; 8(3):e58974. PubMed ID: 23516589
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
18. Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence.
Garibotto V; Borroni B; Kalbe E; Herholz K; Salmon E; Holtoff V; Sorbi S; Cappa SF; Padovani A; Fazio F; Perani D
Neurology; 2008 Oct; 71(17):1342-9. PubMed ID: 18936426
[TBL] [Abstract][Full Text] [Related]
19. Metabolic correlates of cognitive impairment in mesial temporal lobe epilepsy.
Laurent A; Artiges E; Mellerio C; Boutin-Watine M; Landré E; Semah F; Chassoux F
Epilepsy Behav; 2020 Apr; 105():106948. PubMed ID: 32062107
[TBL] [Abstract][Full Text] [Related]
20. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
Mosconi L
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
